References
- Lissauer (initials unknown). Zwei Falle von Leukamie. Berliner Klinische Wochen-shrift 1865; 2: 403–404
- Conan Doyle A. Notes on a case of leucocythaemia. Lancet 25 March, 1882; 490
- Galton D AG. Myleran in chronic myeloid leukaemia. Lancet 1953; i: 208–213
- Galton D AG. Treatment of the chronic leukaemias. Br Med Bulletin 1959; 15: 79–86
- Medical Research Council's Working Party for Therapeutic Trials in Leukaemia. Chronic granulocytic leukaemia: comparison of radiotherapy and busulphan therapy. Br Med J 1968; i: 201–208
- Vicariot M, Goldman J M, Catovsky D, Galton D AG. Treatment of chronic granulocytic leukaemia with repeated single doses of busulphan. Eur J Cancer 1979; 15: 559–563
- Zaccaria A, Valtenti A M, Donti E, et al. Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance with imatinib therapy for chronic myeloid leukaemia. Haematologica 2007; 92: 564–565
- Druker B J, Guilhot F, O'Brien S G, et al. Five-year follow-up of imatinib therapy for newly diagnosed chronic myeloid leukemia in chronic-phase shows sustained responses and high overall survival. New Engl J Med 2006; 355: 2408–2417
- Goldman J, Gordon M Y. Why do stem CML cells survive allogeneic stem cell transplantation or imatinib? Does it really matter?. Leuk Lymphoma 2006; 47: 1–8
- Jamieson C, Ailles L E, Dylla S J, et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. New Engl J Med 2004; 351: 657–667